Policy | July 26, 2022
Funds for R&D in drug discovery and manufacturing :PIB
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Better serving global partners and advancing healthcare innovation
Company raises the annual revenue guidance from mid-teens to high teens
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene's collaboration with Zoetis started in 2011
Subscribe To Our Newsletter & Stay Updated
